DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Chimerix Inc. (CMRX) on Thursday reported a loss of $18.2 million in its fourth quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 20 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The biopharmaceutical company posted revenue of $4,000 in the period.
For the year, the company reported a loss of $82.1 million, or 93 cents per share. Revenue was reported as $324,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX